Literature DB >> 10936678

Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.

T Sameshima1, K Nabeshima, B P Toole, K Yokogami, Y Okada, T Goya, M Koono, S Wakisaka.   

Abstract

Extracellular matrix metalloproteinase inducer (EMMPRIN) also called CD147, basigin or M6 in the human is a member of the immunoglobulin superfamily that is enriched on the surface of tumor cells and stimulates adjacent stromal cells to produce several matrix metalloproteinases (MMPs). In this study, we have demonstrated that coculturing of EMMPRIN-expressing human glioblastoma multiforme cells (U251) with brain-derived human fibroblasts not only stimulates production, but also activation of pro-gelatinase A (proMMP-2), an enzyme that is enriched in malignant gliomas and most likely crucial to tumor progression. Production of membrane types 1 and 2-MMPs (MT1-MMP and MT2-MMP), which are activators of proMMP-2, was also stimulated in these cocultures. Stimulation of MMP-2, MT1-MMP and MT2-MMP production was inhibited by anti-EMMPRIN monoclonal antibody in a dose-dependent manner. Thus, we have shown, for the first time, that EMMPRIN causes increased expression of MT1-MMP and MT2-MMP, as well as increased production and activation of MMP-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936678     DOI: 10.1016/s0304-3835(00)00485-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  52 in total

Review 1.  Proteases at the endometrial-trophoblast interface: their role in implantation.

Authors:  Lois A Salamonsen; Guiying Nie
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Proteomics characterization of cell membrane blebs in human retinal pigment epithelium cells.

Authors:  Oscar Alcazar; Adam M Hawkridge; Timothy S Collier; Scott W Cousins; Sanjoy K Bhattacharya; David C Muddiman; Maria E Marin-Castano
Journal:  Mol Cell Proteomics       Date:  2009-06-29       Impact factor: 5.911

3.  The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis.

Authors:  Sylvia Vong; Raghu Kalluri
Journal:  Genes Cancer       Date:  2011-12

Review 4.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 5.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

6.  EMMPRIN (basigin/CD147) is involved in the morphogenesis of tooth germ in mouse molars.

Authors:  Ming Xie; Ting Jiao; Yuqin Chen; Chun Xu; Jing Li; Xinquan Jiang; Fuqiang Zhang
Journal:  Histochem Cell Biol       Date:  2010-04-06       Impact factor: 4.304

7.  Study of Serum CD147 Level in Patients with Transient Ischemic Attack and CD147 Expression in Atherosclerotic Plaque.

Authors:  Bin Xu; Chan Wu; Wenqing Wu; Yanguo Tan; Nannan Sun; Jian Cui; Siyu Lu; Jing Wang; Shan Cen
Journal:  J Cardiovasc Transl Res       Date:  2018-07-23       Impact factor: 4.132

8.  Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN.

Authors:  Tania R Lizarbe; Carlos Tarín; Mónica Gómez; Begoña Lavin; Enrique Aracil; Luis M Orte; Carlos Zaragoza
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

9.  EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenografts.

Authors:  J Robert Newman; Emily E Helman; Seena Safavy; Wenyue Zhang; Eben L Rosenthal
Journal:  Cancer Lett       Date:  2008-11-05       Impact factor: 8.679

Review 10.  Pancreatic stellate cells--role in pancreas cancer.

Authors:  Max G Bachem; Shaoxia Zhou; Karin Buck; Wilhelm Schneiderhan; Marco Siech
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.